New drug for advanced gynecologic and other solid tumors
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a new drug called BL-M09D1 for people with certain gynecologic cancers or other solid tumors that have not responded to standard treatment. The goal is to see if the drug can shrink tumors or slow their growth, and to check its safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 75.
- You have been diagnosed with a gynecologic cancer (like ovarian, endometrial, or cervical) or another solid tumor that has spread or cannot be removed by surgery.
- Standard treatments have either stopped working or caused side effects you couldn't tolerate.
- You must be able to provide a tumor tissue sample (from a previous biopsy or a new one).
- You need at least one tumor that can be measured on a scan.
- You should be in reasonably good health, able to care for yourself, and have adequate heart, kidney, and liver function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called BL-M08D1 for people with recurrent or metastatic gynecological cancers and other solid tumors. The drug is designed to target and kill cancer cells, and the study aims to see if it is safe and effective.
This trial tests an investigational drug called BL-M09D1 for people with advanced bladder cancer (urothelial carcinoma) or other solid tumors that have spread. The goal is to see if the drug can shrink tumors and help people live longer.
This trial is testing a new drug called BL-M08D for people with melanoma or other solid tumors that have spread. The drug aims to attack cancer cells, and researchers want to see if it is safe and effective.
This study tests a new drug called BL-M08D for people with advanced solid tumors, especially those in the digestive tract (like stomach, colon, or pancreas). The goal is to see if it is safe and effective, and it might help shrink tumors or slow their growth.
This trial is testing an experimental medication called BL-M08D1 for people with head and neck cancer that has come back or spread, as well as other types of solid tumors. The goal is to see if the drug is safe and effective.
This trial tests a new drug called BL-M07D1 for women with HER2-positive or low-HER2 gynecologic cancers that have returned or spread. The drug is designed to target and kill cancer cells that make HER2, and may help when other treatments have stopped working.
Hear when a new Gynecological Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.